Last reviewed · How we verify
PRP Concentrate Arm 1
At a glance
| Generic name | PRP Concentrate Arm 1 |
|---|---|
| Sponsor | Healeon Medical Inc |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy (NA)
- Experimental Study on the Use of Intrauterine Infusion of Autologous Platelet-rich Plasma (PRGF-IUI) in Patients With Recurrent Implantation Failure and/or Refractory Thin Endometrium (NA)
- Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program (NA)
- Connective Tissue Matrix for Rotator Cuff Tendinopathy (PHASE4)
- Corticosteroid Versus PRP Injections for Shoulder Tendinopathy (NA)
- Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis (NA)
- Effect of Platelet Rich Plasma on Photoaged Skin (PHASE1, PHASE2)
- Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRP Concentrate Arm 1 CI brief — competitive landscape report
- PRP Concentrate Arm 1 updates RSS · CI watch RSS
- Healeon Medical Inc portfolio CI